HDFC Bank Regulatory Approval

Management Change

HDFC Bank Management Change

HDFC Bank confirmed that Anup Bagchi assumed charge as MD & CEO effective October 27, 2026, succeeding Sashidhar Jagdishan. The filing also lists the bank's updated KMP contact details.

Debt & Borrowing

HDFC Bank Debt & Borrowing: ₹483 Cr

HDFC Bank confirmed the payment of ₹483 Crore interest on its debt securities (ISIN INE040A08AC9) for the due date of October 22, 2026.

Value

₹483.0 Cr

Employee Stock Options

HDFC Bank Employee Stock Options

HDFC Bank allotted 91,38,522 equity shares to employees upon ESOP/RSU exercise. Paid-up capital rose to 15,42,77,35,870 shares of ₹1 each.

Annual General Meeting

HDFC Bank Annual General Meeting

HDFC Bank issued a postal ballot to re-appoint Mrs. Lily Vadera as Independent Director for three years. E-voting: October 22 to November 20, 2026.

Earnings Call

HDFC Bank Earnings Call Transcript: Key Takeaways

Management focused on a strategic pivot toward customer service efficiency and digital adoption to drive growth while navigating current liquidity constraints.

Management Change

HDFC Bank Management Change

HDFC Bank announced the re-appointment of Mrs. Lily Vadera as Independent Director and the upcoming cessation of service of Mr. Kaizad Bharucha, Deputy Managing Director.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.